| scholarly article | Q13442814 |
| P50 | author | Didier A Mandelbrot | Q88724038 |
| Robert R Redfield III | Q90922948 | ||
| P2093 | author name string | Brad C Astor | |
| Weixiong Zhong | |||
| Fahad Aziz | |||
| Arjang Djamali | |||
| Brenda Muth | |||
| Neetika Garg | |||
| Maha Mohamed | |||
| Sandesh Parajuli | |||
| P2860 | cites work | Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization | Q86568728 |
| Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximab | Q87378832 | ||
| Diagnosis and management of antibody-mediated rejection: current status and novel approaches | Q34841849 | ||
| Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts. | Q37058039 | ||
| Advances in diagnosing and managing antibody-mediated rejection | Q37676032 | ||
| Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum | Q37990375 | ||
| Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale | Q37990988 | ||
| Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria | Q38729874 | ||
| The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. | Q42174325 | ||
| A Critical Appraisal of Methods to Grade Transplant Glomerulitis in Renal Allograft Biopsies | Q42846833 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Kidney allograft survival after acute rejection, the value of follow-up biopsies | Q46211382 | ||
| Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
| Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. | Q47862854 | ||
| Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates | Q48901557 | ||
| Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody-mediated rejection: a pilot study. | Q51002006 | ||
| Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection. | Q53388181 | ||
| One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation | Q56907959 | ||
| C4d deposition in acute rejection: an independent long-term prognostic factor | Q77374161 | ||
| Determinants of poor graft outcome in patients with antibody-mediated acute rejection | Q80054529 | ||
| Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels | Q81964906 | ||
| Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring | Q82425827 | ||
| De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure | Q84752864 | ||
| P433 | issue | 12 | |
| P921 | main subject | rituximab | Q412323 |
| P304 | page(s) | e227 | |
| P577 | publication date | 2017-10-27 | |
| P1433 | published in | Transplantation direct | Q27726309 |
| P1476 | title | Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation. | |
| P478 | volume | 3 |
| Q92803508 | Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure |
| Q64226624 | Glomerular C3 Deposition Is an Independent Risk Factor for Allograft Failure in Kidney Transplant Recipients With Transplant Glomerulopathy |
| Q92899718 | The therapeutic challenge of late antibody-mediated kidney allograft rejection |
Search more.